Dr. Emmanuel Bugarin-Estrada is first author. First-in-Human Phase 1 Study of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Non-Hodgkin Lymphoma. Dr. Ola Landgren is a co-author.